SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (6013)12/29/1998 10:46:00 PM
From: Hank  Read Replies (2) of 7041
 
But wait!!! Did ZONA REALLY make 167K off of Z-Max in 1998?

This was taken from their last 10Q in the EDGAR database:

"Schering-Plough commenced sales of Vasomax(R) in Mexico under the brand name of Z-Max in June 1998. There were no product royalties earned for the quarter ended September 30, 1998, due to the product launch loading into the distribution channel in June 1998."

Then later in the 10Q, management claims that 167K worth of royalties had been derived from the sales of Z-Max in Mexico. It seems that even THEY don't know if they sold any Z-Max or not.

In yet another section of the 10Q, management states that "Substantially all" of their revenues for the 9 months ending on Sept 30, 1998 came from the sale of fertility products through FTI.

Don't you just love unaudited quarterly reports from stand up guys like the ones that run ZONA??
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext